Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.21251360 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21251360 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.93492613 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.93492613 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.50712236 |
6 | tryptophan catabolic process (GO:0006569) | 5.85389986 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.85389986 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.85389986 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.69431859 |
10 | kynurenine metabolic process (GO:0070189) | 5.57316278 |
11 | glyoxylate metabolic process (GO:0046487) | 5.55198827 |
12 | tryptophan metabolic process (GO:0006568) | 5.51490039 |
13 | bile acid biosynthetic process (GO:0006699) | 5.51374672 |
14 | sulfur amino acid catabolic process (GO:0000098) | 5.39311593 |
15 | proteasome assembly (GO:0043248) | 5.16046233 |
16 | cysteine metabolic process (GO:0006534) | 5.14009911 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10035627 |
18 | urea cycle (GO:0000050) | 5.09003823 |
19 | urea metabolic process (GO:0019627) | 5.09003823 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06558498 |
21 | complement activation, alternative pathway (GO:0006957) | 5.06181110 |
22 | negative regulation of fibrinolysis (GO:0051918) | 5.02393573 |
23 | protein carboxylation (GO:0018214) | 4.98028608 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.98028608 |
25 | regulation of protein activation cascade (GO:2000257) | 4.95706438 |
26 | serine family amino acid catabolic process (GO:0009071) | 4.85752810 |
27 | aromatic amino acid family metabolic process (GO:0009072) | 4.82105753 |
28 | regulation of fibrinolysis (GO:0051917) | 4.81827692 |
29 | bile acid metabolic process (GO:0008206) | 4.72975252 |
30 | nitrogen cycle metabolic process (GO:0071941) | 4.69905970 |
31 | homocysteine metabolic process (GO:0050667) | 4.68096576 |
32 | regulation of complement activation (GO:0030449) | 4.65961305 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61708464 |
34 | tyrosine metabolic process (GO:0006570) | 4.55841808 |
35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.55329082 |
36 | regulation of cholesterol esterification (GO:0010872) | 4.55259102 |
37 | regulation of triglyceride catabolic process (GO:0010896) | 4.52506366 |
38 | glycine metabolic process (GO:0006544) | 4.37921897 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.35294109 |
40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34795024 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.34795024 |
42 | macromolecular complex remodeling (GO:0034367) | 4.34795024 |
43 | alpha-amino acid catabolic process (GO:1901606) | 4.34654218 |
44 | bile acid and bile salt transport (GO:0015721) | 4.32885860 |
45 | reverse cholesterol transport (GO:0043691) | 4.31900143 |
46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.31505459 |
47 | coenzyme catabolic process (GO:0009109) | 4.25506556 |
48 | lysine metabolic process (GO:0006553) | 4.25306929 |
49 | lysine catabolic process (GO:0006554) | 4.25306929 |
50 | aldehyde catabolic process (GO:0046185) | 4.24982512 |
51 | acylglycerol homeostasis (GO:0055090) | 4.23699503 |
52 | triglyceride homeostasis (GO:0070328) | 4.23699503 |
53 | serine family amino acid biosynthetic process (GO:0009070) | 4.21112936 |
54 | indolalkylamine metabolic process (GO:0006586) | 4.19504322 |
55 | phospholipid efflux (GO:0033700) | 4.18827054 |
56 | serine family amino acid metabolic process (GO:0009069) | 4.17016463 |
57 | negative regulation of cholesterol transport (GO:0032375) | 4.16483519 |
58 | negative regulation of sterol transport (GO:0032372) | 4.16483519 |
59 | amine catabolic process (GO:0009310) | 4.16065347 |
60 | cellular biogenic amine catabolic process (GO:0042402) | 4.16065347 |
61 | cellular glucuronidation (GO:0052695) | 4.12315470 |
62 | imidazole-containing compound metabolic process (GO:0052803) | 4.08864222 |
63 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.08171309 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 4.07600761 |
65 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.06463871 |
66 | cellular amino acid catabolic process (GO:0009063) | 4.03303292 |
67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.02287936 |
68 | cellular ketone body metabolic process (GO:0046950) | 4.01077732 |
69 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.97782098 |
70 | ethanol oxidation (GO:0006069) | 3.96532594 |
71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.93780412 |
72 | ATP synthesis coupled proton transport (GO:0015986) | 3.93780412 |
73 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.93219629 |
74 | negative regulation of ligase activity (GO:0051352) | 3.93219629 |
75 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.92876096 |
76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.92170323 |
77 | cofactor catabolic process (GO:0051187) | 3.90815154 |
78 | benzene-containing compound metabolic process (GO:0042537) | 3.87238843 |
79 | cholesterol efflux (GO:0033344) | 3.87046947 |
80 | cellular modified amino acid catabolic process (GO:0042219) | 3.80212219 |
81 | DNA strand elongation (GO:0022616) | 3.74945162 |
82 | drug catabolic process (GO:0042737) | 3.74871329 |
83 | glucuronate metabolic process (GO:0019585) | 3.73910894 |
84 | uronic acid metabolic process (GO:0006063) | 3.73910894 |
85 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.73510534 |
86 | fibrinolysis (GO:0042730) | 3.71868106 |
87 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.70952631 |
88 | glutamate metabolic process (GO:0006536) | 3.69737604 |
89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69580532 |
90 | arginine metabolic process (GO:0006525) | 3.69482444 |
91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67056345 |
92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67056345 |
93 | chaperone-mediated protein transport (GO:0072321) | 3.66814510 |
94 | NAD biosynthetic process (GO:0009435) | 3.66476236 |
95 | short-chain fatty acid metabolic process (GO:0046459) | 3.65636499 |
96 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.65448247 |
97 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.65448247 |
98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.65448247 |
99 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.64761717 |
100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.64761717 |
101 | acetyl-CoA metabolic process (GO:0006084) | 3.64009325 |
102 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.63138083 |
103 | plasma lipoprotein particle assembly (GO:0034377) | 3.62939079 |
104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61231003 |
105 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59904485 |
106 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59904485 |
107 | organic acid catabolic process (GO:0016054) | 3.59788255 |
108 | carboxylic acid catabolic process (GO:0046395) | 3.59788255 |
109 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.58664710 |
110 | heme transport (GO:0015886) | 3.58419258 |
111 | chromatin remodeling at centromere (GO:0031055) | 3.57305949 |
112 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.55379551 |
113 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.55379551 |
114 | complement activation (GO:0006956) | 3.55323600 |
115 | DNA replication checkpoint (GO:0000076) | 3.55297206 |
116 | complement activation, classical pathway (GO:0006958) | 3.55268165 |
117 | cholesterol homeostasis (GO:0042632) | 3.54985755 |
118 | respiratory electron transport chain (GO:0022904) | 3.54166252 |
119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52008788 |
120 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.50768976 |
121 | opsonization (GO:0008228) | 3.50356002 |
122 | CENP-A containing nucleosome assembly (GO:0034080) | 3.49858154 |
123 | protein activation cascade (GO:0072376) | 3.48933834 |
124 | ketone body metabolic process (GO:1902224) | 3.48622767 |
125 | sterol homeostasis (GO:0055092) | 3.47895963 |
126 | electron transport chain (GO:0022900) | 3.45322771 |
127 | positive regulation of ligase activity (GO:0051351) | 3.42854957 |
128 | regulation of mitochondrial translation (GO:0070129) | 3.41273646 |
129 | cullin deneddylation (GO:0010388) | 3.40248201 |
130 | L-serine metabolic process (GO:0006563) | 3.39751871 |
131 | urate metabolic process (GO:0046415) | 3.37700014 |
132 | cytolysis (GO:0019835) | 3.36173759 |
133 | rRNA modification (GO:0000154) | 3.35338344 |
134 | regulation of bile acid biosynthetic process (GO:0070857) | 3.33442691 |
135 | drug metabolic process (GO:0017144) | 3.32429996 |
136 | regulation of cholesterol metabolic process (GO:0090181) | 3.32034590 |
137 | protein complex biogenesis (GO:0070271) | 3.31277033 |
138 | telomere maintenance via recombination (GO:0000722) | 3.28343899 |
139 | respiratory chain complex IV assembly (GO:0008535) | 3.27642864 |
140 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.27550873 |
141 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.24464997 |
142 | purine nucleobase biosynthetic process (GO:0009113) | 3.23926954 |
143 | protein deneddylation (GO:0000338) | 3.23692725 |
144 | termination of RNA polymerase III transcription (GO:0006386) | 3.20820131 |
145 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.20820131 |
146 | pseudouridine synthesis (GO:0001522) | 3.18512592 |
147 | nucleobase biosynthetic process (GO:0046112) | 3.15461611 |
148 | mitotic recombination (GO:0006312) | 3.15231791 |
149 | establishment of integrated proviral latency (GO:0075713) | 3.14630940 |
150 | DNA double-strand break processing (GO:0000729) | 3.13839597 |
151 | regulation of cellular amine metabolic process (GO:0033238) | 3.12997094 |
152 | regulation of ligase activity (GO:0051340) | 3.12617436 |
153 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.05926734 |
154 | mitotic sister chromatid segregation (GO:0000070) | 3.05093040 |
155 | protein targeting to mitochondrion (GO:0006626) | 3.03782078 |
156 | protein maturation by protein folding (GO:0022417) | 3.02910821 |
157 | kinetochore organization (GO:0051383) | 3.02744343 |
158 | kinetochore assembly (GO:0051382) | 3.02396470 |
159 | replication fork processing (GO:0031297) | 3.01725719 |
160 | cytochrome complex assembly (GO:0017004) | 2.99303186 |
161 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.99192989 |
162 | * cholesterol biosynthetic process (GO:0006695) | 2.98621430 |
163 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.96350558 |
164 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.96350558 |
165 | NADH dehydrogenase complex assembly (GO:0010257) | 2.96350558 |
166 | mitotic metaphase plate congression (GO:0007080) | 2.95423132 |
167 | histone exchange (GO:0043486) | 2.95368748 |
168 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93276578 |
169 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93096981 |
170 | inner mitochondrial membrane organization (GO:0007007) | 2.90716124 |
171 | protein neddylation (GO:0045116) | 2.88551632 |
172 | oxidative phosphorylation (GO:0006119) | 2.87755758 |
173 | protein localization to kinetochore (GO:0034501) | 2.85439943 |
174 | resolution of meiotic recombination intermediates (GO:0000712) | 2.83413513 |
175 | telomere maintenance via telomere lengthening (GO:0010833) | 2.83228322 |
176 | tricarboxylic acid cycle (GO:0006099) | 2.82882052 |
177 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82059522 |
178 | DNA damage response, detection of DNA damage (GO:0042769) | 2.81280031 |
179 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.81011994 |
180 | cell cycle G1/S phase transition (GO:0044843) | 2.81011994 |
181 | establishment of protein localization to mitochondrion (GO:0072655) | 2.78913211 |
182 | * sterol biosynthetic process (GO:0016126) | 2.78827870 |
183 | positive regulation of cell cycle arrest (GO:0071158) | 2.78421035 |
184 | protein-cofactor linkage (GO:0018065) | 2.77248145 |
185 | protein localization to mitochondrion (GO:0070585) | 2.77114601 |
186 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.77009227 |
187 | ribosome assembly (GO:0042255) | 2.76448586 |
188 | spliceosomal snRNP assembly (GO:0000387) | 2.73710337 |
189 | DNA replication initiation (GO:0006270) | 2.70851213 |
190 | metaphase plate congression (GO:0051310) | 2.70747192 |
191 | rRNA methylation (GO:0031167) | 2.70199779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.39224537 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.67407231 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.47433781 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.45831219 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.55791796 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11555194 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82140207 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.59989644 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06478311 |
10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.56732224 |
11 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.54670474 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.13001801 |
13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05911779 |
14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.99093309 |
15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.92604945 |
16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.65956418 |
17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.65640208 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64358887 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63053335 |
20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.34082203 |
21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.31167656 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.24172612 |
23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.20803703 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.19514029 |
25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17843354 |
26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13814329 |
27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.11082958 |
28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6223288 |
29 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.99590973 |
30 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97946746 |
31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97688837 |
32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91359380 |
33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83275248 |
34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82533120 |
35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.80676656 |
36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78791709 |
37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78111774 |
38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73689135 |
39 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72632968 |
40 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68246597 |
41 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67177632 |
42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64991321 |
43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62269108 |
44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56779434 |
45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54690972 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52944095 |
47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51189399 |
48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47668503 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46715511 |
50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45594801 |
51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41194638 |
52 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40004672 |
53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37101255 |
54 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32477462 |
55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32326431 |
56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27279030 |
57 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25437730 |
58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25039908 |
59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23524224 |
60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21924558 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21095112 |
62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20565408 |
63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19165477 |
64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17018970 |
65 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14742321 |
66 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13427158 |
67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11063229 |
68 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11041192 |
69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10571725 |
70 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09623437 |
71 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07388169 |
72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07085294 |
73 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.05486677 |
74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04689763 |
75 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03932072 |
76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03199091 |
77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01941316 |
78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.01167481 |
79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00667280 |
80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.98871120 |
81 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.98807433 |
82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97827138 |
83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96467074 |
84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96221459 |
85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95964821 |
86 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94822801 |
87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94241896 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93413210 |
89 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93001978 |
90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92713991 |
91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91881871 |
92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91670743 |
93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90613427 |
94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89078730 |
95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88680632 |
96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88428357 |
97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.87852854 |
98 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87586356 |
99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87016673 |
100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86795844 |
101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85188518 |
102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84386123 |
103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83643990 |
104 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81761661 |
105 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81737426 |
106 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.81730114 |
107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80987623 |
108 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.80227823 |
109 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.79801383 |
110 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.78875549 |
111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.77777205 |
112 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.77231630 |
113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77229504 |
114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73605161 |
115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73575258 |
116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73001900 |
117 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.72878310 |
118 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.71287084 |
119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70810596 |
120 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.70080338 |
121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.69876146 |
122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69727319 |
123 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.69635837 |
124 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.69559725 |
125 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.69398742 |
126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.68955750 |
127 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.68071131 |
128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67762176 |
129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66519728 |
130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64021077 |
131 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.62814065 |
132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62605826 |
133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62317090 |
134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61994090 |
135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61290449 |
136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.61046662 |
137 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.60200073 |
138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.58692302 |
139 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.58631558 |
140 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.58369184 |
141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.58168817 |
142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57925314 |
143 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.57612012 |
144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57249836 |
145 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57132779 |
146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.56748888 |
147 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56678410 |
148 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.55958250 |
149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.55492846 |
150 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.55125196 |
151 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.55000183 |
152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54527159 |
153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.54309968 |
154 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.53760776 |
155 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.53114320 |
156 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.53022210 |
157 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.52489728 |
158 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51206096 |
159 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.51078596 |
160 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50557146 |
161 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50044135 |
162 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.49988161 |
163 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49959467 |
164 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49698730 |
165 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.49092311 |
166 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.48853501 |
167 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48779628 |
168 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.48746354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.63316251 |
2 | MP0005360_urolithiasis | 7.02664460 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.92080979 |
4 | MP0005365_abnormal_bile_salt | 5.66204206 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.89641686 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.61526894 |
7 | MP0003693_abnormal_embryo_hatching | 3.94563653 |
8 | MP0010094_abnormal_chromosome_stability | 3.93503939 |
9 | MP0003252_abnormal_bile_duct | 3.51687625 |
10 | MP0008058_abnormal_DNA_repair | 3.50238815 |
11 | MP0009840_abnormal_foam_cell | 3.36744624 |
12 | MP0010329_abnormal_lipoprotein_level | 3.22378267 |
13 | MP0004957_abnormal_blastocyst_morpholog | 3.19072209 |
14 | MP0003195_calcinosis | 3.06045033 |
15 | MP0003111_abnormal_nucleus_morphology | 2.91320411 |
16 | MP0005083_abnormal_biliary_tract | 2.90044054 |
17 | MP0005332_abnormal_amino_acid | 2.75686202 |
18 | MP0001666_abnormal_nutrient_absorption | 2.58108989 |
19 | MP0008932_abnormal_embryonic_tissue | 2.53084867 |
20 | MP0003786_premature_aging | 2.48082824 |
21 | MP0003077_abnormal_cell_cycle | 2.40357701 |
22 | MP0008007_abnormal_cellular_replicative | 2.36593595 |
23 | MP0003123_paternal_imprinting | 2.33653480 |
24 | MP0003191_abnormal_cellular_cholesterol | 2.31151332 |
25 | MP0000372_irregular_coat_pigmentation | 2.29504991 |
26 | MP0004019_abnormal_vitamin_homeostasis | 2.26383479 |
27 | MP0000609_abnormal_liver_physiology | 2.09821295 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.98305916 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.96540349 |
30 | MP0008057_abnormal_DNA_replication | 1.95302674 |
31 | MP0006292_abnormal_olfactory_placode | 1.92664834 |
32 | MP0002938_white_spotting | 1.90494482 |
33 | MP0001764_abnormal_homeostasis | 1.89232739 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.87136919 |
35 | MP0003186_abnormal_redox_activity | 1.82924936 |
36 | MP0008877_abnormal_DNA_methylation | 1.68544694 |
37 | MP0001529_abnormal_vocalization | 1.66914732 |
38 | MP0005451_abnormal_body_composition | 1.65178630 |
39 | MP0003121_genomic_imprinting | 1.64395969 |
40 | MP0003868_abnormal_feces_composition | 1.63199012 |
41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60316600 |
42 | MP0003656_abnormal_erythrocyte_physiolo | 1.58999101 |
43 | MP0002102_abnormal_ear_morphology | 1.48201872 |
44 | MP0009643_abnormal_urine_homeostasis | 1.47632745 |
45 | MP0002163_abnormal_gland_morphology | 1.47593710 |
46 | MP0003941_abnormal_skin_development | 1.47504813 |
47 | MP0003011_delayed_dark_adaptation | 1.39586086 |
48 | MP0009697_abnormal_copulation | 1.35830983 |
49 | MP0010030_abnormal_orbit_morphology | 1.33265776 |
50 | MP0001293_anophthalmia | 1.28485579 |
51 | MP0008995_early_reproductive_senescence | 1.24761561 |
52 | MP0000598_abnormal_liver_morphology | 1.20587235 |
53 | MP0008469_abnormal_protein_level | 1.16699009 |
54 | MP0005636_abnormal_mineral_homeostasis | 1.16205641 |
55 | MP0009764_decreased_sensitivity_to | 1.16025893 |
56 | MP0002210_abnormal_sex_determination | 1.15119338 |
57 | MP0000358_abnormal_cell_content/ | 1.14797209 |
58 | MP0002234_abnormal_pharynx_morphology | 1.13280215 |
59 | MP0001929_abnormal_gametogenesis | 1.10750738 |
60 | MP0009763_increased_sensitivity_to | 1.09087162 |
61 | MP0003122_maternal_imprinting | 1.08846478 |
62 | MP0003890_abnormal_embryonic-extraembry | 1.07884607 |
63 | MP0001730_embryonic_growth_arrest | 1.06822580 |
64 | MP0001697_abnormal_embryo_size | 1.05906672 |
65 | MP0006036_abnormal_mitochondrial_physio | 1.05547285 |
66 | MP0000604_amyloidosis | 1.05497736 |
67 | MP0000647_abnormal_sebaceous_gland | 1.05148393 |
68 | MP0005408_hypopigmentation | 1.01541068 |
69 | MP0008872_abnormal_physiological_respon | 1.01430729 |
70 | MP0006072_abnormal_retinal_apoptosis | 1.00463602 |
71 | MP0005647_abnormal_sex_gland | 0.99079679 |
72 | MP0005084_abnormal_gallbladder_morpholo | 0.97679202 |
73 | MP0003436_decreased_susceptibility_to | 0.96917435 |
74 | MP0000653_abnormal_sex_gland | 0.95595586 |
75 | MP0005058_abnormal_lysosome_morphology | 0.94482825 |
76 | MP0008789_abnormal_olfactory_epithelium | 0.94374761 |
77 | MP0005379_endocrine/exocrine_gland_phen | 0.94172731 |
78 | MP0002736_abnormal_nociception_after | 0.93571258 |
79 | MP0002160_abnormal_reproductive_system | 0.93331205 |
80 | MP0002090_abnormal_vision | 0.93188774 |
81 | MP0003724_increased_susceptibility_to | 0.92806840 |
82 | MP0003119_abnormal_digestive_system | 0.91900798 |
83 | MP0001145_abnormal_male_reproductive | 0.91817580 |
84 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90250172 |
85 | MP0009642_abnormal_blood_homeostasis | 0.89360613 |
86 | MP0009765_abnormal_xenobiotic_induced | 0.88480577 |
87 | MP0003937_abnormal_limbs/digits/tail_de | 0.87919575 |
88 | MP0005376_homeostasis/metabolism_phenot | 0.87210932 |
89 | MP0005380_embryogenesis_phenotype | 0.85687773 |
90 | MP0001672_abnormal_embryogenesis/_devel | 0.85687773 |
91 | MP0005389_reproductive_system_phenotype | 0.85550527 |
92 | MP0003718_maternal_effect | 0.84855384 |
93 | MP0003315_abnormal_perineum_morphology | 0.84147909 |
94 | MP0000350_abnormal_cell_proliferation | 0.83980820 |
95 | MP0006082_CNS_inflammation | 0.82153453 |
96 | MP0002876_abnormal_thyroid_physiology | 0.81284401 |
97 | MP0001756_abnormal_urination | 0.80862067 |
98 | MP0001919_abnormal_reproductive_system | 0.80477932 |
99 | MP0002080_prenatal_lethality | 0.80125539 |
100 | MP0003705_abnormal_hypodermis_morpholog | 0.79603265 |
101 | MP0001119_abnormal_female_reproductive | 0.79522152 |
102 | MP0004782_abnormal_surfactant_physiolog | 0.76974368 |
103 | MP0000313_abnormal_cell_death | 0.76763438 |
104 | MP0001661_extended_life_span | 0.76575373 |
105 | MP0005464_abnormal_platelet_physiology | 0.76540799 |
106 | MP0003950_abnormal_plasma_membrane | 0.75897504 |
107 | MP0009672_abnormal_birth_weight | 0.74004375 |
108 | MP0005394_taste/olfaction_phenotype | 0.73488019 |
109 | MP0005499_abnormal_olfactory_system | 0.73488019 |
110 | MP0009785_altered_susceptibility_to | 0.73442473 |
111 | MP0002282_abnormal_trachea_morphology | 0.73095083 |
112 | MP0005220_abnormal_exocrine_pancreas | 0.72826060 |
113 | MP0002085_abnormal_embryonic_tissue | 0.72692912 |
114 | MP0001324_abnormal_eye_pigmentation | 0.72261169 |
115 | MP0000516_abnormal_urinary_system | 0.71830296 |
116 | MP0005367_renal/urinary_system_phenotyp | 0.71830296 |
117 | MP0001286_abnormal_eye_development | 0.71648024 |
118 | MP0005266_abnormal_metabolism | 0.70172209 |
119 | MP0002233_abnormal_nose_morphology | 0.69512568 |
120 | MP0006035_abnormal_mitochondrial_morpho | 0.68414686 |
121 | MP0002084_abnormal_developmental_patter | 0.66662828 |
122 | MP0002254_reproductive_system_inflammat | 0.65830711 |
123 | MP0005551_abnormal_eye_electrophysiolog | 0.65575924 |
124 | MP0002078_abnormal_glucose_homeostasis | 0.64653537 |
125 | MP0003984_embryonic_growth_retardation | 0.64529078 |
126 | MP0002136_abnormal_kidney_physiology | 0.64484845 |
127 | MP0002088_abnormal_embryonic_growth/wei | 0.64377603 |
128 | MP0005395_other_phenotype | 0.63136713 |
129 | MP0001845_abnormal_inflammatory_respons | 0.61620616 |
130 | MP0005670_abnormal_white_adipose | 0.60957532 |
131 | MP0002132_abnormal_respiratory_system | 0.60159477 |
132 | MP0005334_abnormal_fat_pad | 0.59577039 |
133 | MP0004381_abnormal_hair_follicle | 0.59410775 |
134 | MP0005025_abnormal_response_to | 0.58878147 |
135 | MP0003690_abnormal_glial_cell | 0.58269246 |
136 | MP0008873_increased_physiological_sensi | 0.57735748 |
137 | MP0010368_abnormal_lymphatic_system | 0.56575754 |
138 | MP0002971_abnormal_brown_adipose | 0.54880609 |
139 | MP0002419_abnormal_innate_immunity | 0.53919552 |
140 | MP0002796_impaired_skin_barrier | 0.52256235 |
141 | MP0001835_abnormal_antigen_presentation | 0.51957679 |
142 | MP0009053_abnormal_anal_canal | 0.51874134 |
143 | MP0003329_amyloid_beta_deposits | 0.51832933 |
144 | MP0005535_abnormal_body_temperature | 0.50573609 |
145 | MP0003638_abnormal_response/metabolism_ | 0.49915586 |
146 | MP0004147_increased_porphyrin_level | 0.46876208 |
147 | MP0003075_altered_response_to | 0.45543328 |
148 | MP0001243_abnormal_dermal_layer | 0.45228532 |
149 | MP0004947_skin_inflammation | 0.45175872 |
150 | MP0000639_abnormal_adrenal_gland | 0.44370327 |
151 | MP0001853_heart_inflammation | 0.44318099 |
152 | MP0005075_abnormal_melanosome_morpholog | 0.43846657 |
153 | MP0005448_abnormal_energy_balance | 0.43525043 |
154 | MP0005166_decreased_susceptibility_to | 0.42548263 |
155 | MP0001881_abnormal_mammary_gland | 0.41461129 |
156 | MP0001533_abnormal_skeleton_physiology | 0.41449258 |
157 | MP0010155_abnormal_intestine_physiology | 0.41081070 |
158 | MP0000685_abnormal_immune_system | 0.39521902 |
159 | MP0001542_abnormal_bone_strength | 0.38974702 |
160 | MP0004130_abnormal_muscle_cell | 0.36064782 |
161 | MP0000249_abnormal_blood_vessel | 0.35857663 |
162 | MP0002928_abnormal_bile_duct | 0.34901038 |
163 | MP0001790_abnormal_immune_system | 0.34215324 |
164 | MP0005387_immune_system_phenotype | 0.34215324 |
165 | MP0004043_abnormal_pH_regulation | 0.34186226 |
166 | MP0004264_abnormal_extraembryonic_tissu | 0.33118147 |
167 | MP0002060_abnormal_skin_morphology | 0.33106166 |
168 | MP0001800_abnormal_humoral_immune | 0.32897809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03585547 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.71551151 |
3 | Deep venous thrombosis (HP:0002625) | 6.38280418 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.23379189 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 5.93275293 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.90467878 |
7 | Xanthomatosis (HP:0000991) | 5.78912576 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.06937923 |
9 | Acute necrotizing encephalopathy (HP:0006965) | 4.88659174 |
10 | Complement deficiency (HP:0004431) | 4.86423786 |
11 | Acute encephalopathy (HP:0006846) | 4.70984680 |
12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.64475665 |
13 | Joint hemorrhage (HP:0005261) | 4.45292338 |
14 | Hyperglycinemia (HP:0002154) | 4.38616414 |
15 | Hyperammonemia (HP:0001987) | 4.34324775 |
16 | Hypolipoproteinemia (HP:0010981) | 4.26694221 |
17 | Increased serum pyruvate (HP:0003542) | 4.15073325 |
18 | Abnormality of methionine metabolism (HP:0010901) | 4.13029402 |
19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07657647 |
20 | Abnormality of glycolysis (HP:0004366) | 4.07123508 |
21 | Mitochondrial inheritance (HP:0001427) | 4.06243147 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05723216 |
23 | Increased CSF lactate (HP:0002490) | 4.00993145 |
24 | Progressive macrocephaly (HP:0004481) | 3.99810451 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97820658 |
26 | Hyperglycinuria (HP:0003108) | 3.96960195 |
27 | Fat malabsorption (HP:0002630) | 3.96290548 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.94230229 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94230229 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93422535 |
31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90970172 |
32 | Ketosis (HP:0001946) | 3.85530712 |
33 | Hepatocellular necrosis (HP:0001404) | 3.84827281 |
34 | Epidermoid cyst (HP:0200040) | 3.83598799 |
35 | Hypoglycemic coma (HP:0001325) | 3.78955188 |
36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.75492386 |
37 | Abnormality of complement system (HP:0005339) | 3.69310007 |
38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55212597 |
39 | Hypoalphalipoproteinemia (HP:0003233) | 3.54989539 |
40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46330982 |
41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40799682 |
42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36490881 |
43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.23062594 |
44 | Hypercholesterolemia (HP:0003124) | 3.20278023 |
45 | Hyperbilirubinemia (HP:0002904) | 3.19951837 |
46 | Steatorrhea (HP:0002570) | 3.15087477 |
47 | Increased hepatocellular lipid droplets (HP:0006565) | 3.14422515 |
48 | Abnormality of serum amino acid levels (HP:0003112) | 3.09107799 |
49 | Delayed CNS myelination (HP:0002188) | 3.04957352 |
50 | Increased serum lactate (HP:0002151) | 3.04801398 |
51 | Systemic lupus erythematosus (HP:0002725) | 3.04486054 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03307185 |
53 | Chromsome breakage (HP:0040012) | 2.96715329 |
54 | Dicarboxylic aciduria (HP:0003215) | 2.95692797 |
55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95692797 |
56 | Lipid accumulation in hepatocytes (HP:0006561) | 2.94894098 |
57 | Renal Fanconi syndrome (HP:0001994) | 2.92099371 |
58 | Lethargy (HP:0001254) | 2.84443092 |
59 | Lactic acidosis (HP:0003128) | 2.83193466 |
60 | Reticulocytopenia (HP:0001896) | 2.79305828 |
61 | Hepatocellular carcinoma (HP:0001402) | 2.76570678 |
62 | Myocardial infarction (HP:0001658) | 2.75342244 |
63 | Metabolic acidosis (HP:0001942) | 2.71454354 |
64 | Abnormality of the preputium (HP:0100587) | 2.71442456 |
65 | Meckel diverticulum (HP:0002245) | 2.70702074 |
66 | Ketoacidosis (HP:0001993) | 2.70073040 |
67 | Abnormality of purine metabolism (HP:0004352) | 2.67214585 |
68 | Cerebral edema (HP:0002181) | 2.62950884 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61847293 |
70 | Gout (HP:0001997) | 2.60282978 |
71 | Type I transferrin isoform profile (HP:0003642) | 2.58705058 |
72 | Abnormality of the ileum (HP:0001549) | 2.58335989 |
73 | Spontaneous abortion (HP:0005268) | 2.54224995 |
74 | Generalized aminoaciduria (HP:0002909) | 2.53793196 |
75 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.53145893 |
76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.53124858 |
77 | Abnormality of alanine metabolism (HP:0010916) | 2.53124858 |
78 | Hyperalaninemia (HP:0003348) | 2.53124858 |
79 | Glomerulonephritis (HP:0000099) | 2.48590882 |
80 | Vascular calcification (HP:0004934) | 2.47496068 |
81 | Respiratory failure (HP:0002878) | 2.46411141 |
82 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.44782652 |
83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.44782652 |
84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.44593718 |
85 | Irritability (HP:0000737) | 2.40775576 |
86 | Hypochromic microcytic anemia (HP:0004840) | 2.38338676 |
87 | Exercise intolerance (HP:0003546) | 2.38080745 |
88 | Horseshoe kidney (HP:0000085) | 2.36384512 |
89 | Acanthocytosis (HP:0001927) | 2.36236727 |
90 | Skin nodule (HP:0200036) | 2.35587714 |
91 | Abnormal lung lobation (HP:0002101) | 2.35362219 |
92 | Abnormality of the labia minora (HP:0012880) | 2.34202485 |
93 | Abnormality of chromosome stability (HP:0003220) | 2.29608649 |
94 | Leukodystrophy (HP:0002415) | 2.28237927 |
95 | Abnormal gallbladder morphology (HP:0012437) | 2.27915714 |
96 | Respiratory difficulties (HP:0002880) | 2.27379142 |
97 | Hypoglycemic seizures (HP:0002173) | 2.26708195 |
98 | Methylmalonic aciduria (HP:0012120) | 2.26362739 |
99 | Reduced antithrombin III activity (HP:0001976) | 2.25678656 |
100 | Spastic diplegia (HP:0001264) | 2.25155247 |
101 | Abnormal cartilage morphology (HP:0002763) | 2.24364237 |
102 | Optic disc pallor (HP:0000543) | 2.23166789 |
103 | Amyloidosis (HP:0011034) | 2.22042651 |
104 | Vomiting (HP:0002013) | 2.21848023 |
105 | CNS demyelination (HP:0007305) | 2.21056398 |
106 | Hypoplastic pelvis (HP:0008839) | 2.20558401 |
107 | Opisthotonus (HP:0002179) | 2.19945656 |
108 | Pancreatitis (HP:0001733) | 2.19079716 |
109 | Gingival bleeding (HP:0000225) | 2.18329289 |
110 | Methylmalonic acidemia (HP:0002912) | 2.17996725 |
111 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17960076 |
112 | Cholelithiasis (HP:0001081) | 2.16378961 |
113 | Cardiovascular calcification (HP:0011915) | 2.16068350 |
114 | Duodenal stenosis (HP:0100867) | 2.11575835 |
115 | Small intestinal stenosis (HP:0012848) | 2.11575835 |
116 | Abnormality of iron homeostasis (HP:0011031) | 2.10665601 |
117 | Birth length less than 3rd percentile (HP:0003561) | 2.09968812 |
118 | Abnormal glycosylation (HP:0012345) | 2.09766726 |
119 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09766726 |
120 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09766726 |
121 | Abnormal protein glycosylation (HP:0012346) | 2.09766726 |
122 | Brushfield spots (HP:0001088) | 2.09619965 |
123 | Malnutrition (HP:0004395) | 2.07839777 |
124 | Renal cortical cysts (HP:0000803) | 2.06422604 |
125 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06092504 |
126 | Cholecystitis (HP:0001082) | 2.06089529 |
127 | Abnormal gallbladder physiology (HP:0012438) | 2.06089529 |
128 | Pancytopenia (HP:0001876) | 2.05420003 |
129 | Abnormality of urine glucose concentration (HP:0011016) | 2.04526361 |
130 | Glycosuria (HP:0003076) | 2.04526361 |
131 | Absent thumb (HP:0009777) | 2.03356684 |
132 | * X-linked dominant inheritance (HP:0001423) | 2.01967598 |
133 | Neonatal onset (HP:0003623) | 2.01857535 |
134 | Increased muscle lipid content (HP:0009058) | 2.01190348 |
135 | Colon cancer (HP:0003003) | 2.00915418 |
136 | Bifid tongue (HP:0010297) | 2.00077626 |
137 | Mitral stenosis (HP:0001718) | 1.99939220 |
138 | Nausea (HP:0002018) | 1.98986978 |
139 | Rickets (HP:0002748) | 1.96870329 |
140 | Late onset (HP:0003584) | 1.96813470 |
141 | Proximal tubulopathy (HP:0000114) | 1.95061476 |
142 | Esophageal varix (HP:0002040) | 1.94810744 |
143 | Thrombophlebitis (HP:0004418) | 1.93336291 |
144 | Abnormality of the duodenum (HP:0002246) | 1.92954507 |
145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92571863 |
146 | Menorrhagia (HP:0000132) | 1.91474387 |
147 | Alkalosis (HP:0001948) | 1.91451943 |
148 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90897374 |
149 | Hyperphosphaturia (HP:0003109) | 1.89824708 |
150 | Abnormality of the gallbladder (HP:0005264) | 1.89674060 |
151 | Poikilocytosis (HP:0004447) | 1.89071968 |
152 | Cerebral hypomyelination (HP:0006808) | 1.87394464 |
153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.85309112 |
154 | Sensorimotor neuropathy (HP:0007141) | 1.85107197 |
155 | Elevated hepatic transaminases (HP:0002910) | 1.84765442 |
156 | Hypophosphatemic rickets (HP:0004912) | 1.82928060 |
157 | Hepatic necrosis (HP:0002605) | 1.82742756 |
158 | Increased serum ferritin (HP:0003281) | 1.82247465 |
159 | 3-Methylglutaconic aciduria (HP:0003535) | 1.81661909 |
160 | Multiple enchondromatosis (HP:0005701) | 1.81354668 |
161 | Microvesicular hepatic steatosis (HP:0001414) | 1.79668275 |
162 | Vacuolated lymphocytes (HP:0001922) | 1.78981386 |
163 | Hemorrhage of the eye (HP:0011885) | 1.77874614 |
164 | Hydroxyprolinuria (HP:0003080) | 1.77096564 |
165 | Adrenal hypoplasia (HP:0000835) | 1.76489019 |
166 | Exertional dyspnea (HP:0002875) | 1.76231328 |
167 | Abnormality of the anterior horn cell (HP:0006802) | 1.74212874 |
168 | Degeneration of anterior horn cells (HP:0002398) | 1.74212874 |
169 | Ependymoma (HP:0002888) | 1.70957529 |
170 | Macrocytic anemia (HP:0001972) | 1.70627979 |
171 | Megaloblastic anemia (HP:0001889) | 1.69097615 |
172 | Abnormality of renal resorption (HP:0011038) | 1.69052287 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.47288667 |
2 | TAOK3 | 4.63551780 |
3 | ERN1 | 3.89164189 |
4 | FGFR4 | 3.74128781 |
5 | VRK2 | 3.64399732 |
6 | NEK1 | 3.43022075 |
7 | SIK1 | 2.78930074 |
8 | MST1R | 2.69520840 |
9 | CDC7 | 2.68935634 |
10 | PDK2 | 2.54722332 |
11 | SRPK1 | 2.44106227 |
12 | ZAK | 2.38112778 |
13 | TRIM28 | 2.29676998 |
14 | INSRR | 2.28192549 |
15 | TTK | 2.22489461 |
16 | BRSK2 | 2.21859802 |
17 | PLK3 | 2.17662918 |
18 | TSSK6 | 2.13159565 |
19 | FLT3 | 2.09792177 |
20 | PLK4 | 2.09297699 |
21 | TYK2 | 2.08260540 |
22 | ERBB4 | 2.00937891 |
23 | TBK1 | 1.94661226 |
24 | NME2 | 1.91854054 |
25 | KDR | 1.90518384 |
26 | VRK1 | 1.87356671 |
27 | BRSK1 | 1.85815227 |
28 | PIK3CG | 1.82250445 |
29 | MAP3K14 | 1.78864110 |
30 | ABL2 | 1.74366698 |
31 | WNK3 | 1.65491592 |
32 | NME1 | 1.65437653 |
33 | PBK | 1.63275756 |
34 | MAPK11 | 1.62820804 |
35 | MAP3K12 | 1.60216551 |
36 | PLK1 | 1.53866656 |
37 | STK16 | 1.44988899 |
38 | GRK6 | 1.44698425 |
39 | BMPR1B | 1.42584254 |
40 | IRAK3 | 1.42308322 |
41 | NEK9 | 1.34329737 |
42 | MKNK2 | 1.30111776 |
43 | EPHB1 | 1.27455070 |
44 | CHEK2 | 1.22698633 |
45 | MAP4K1 | 1.22444768 |
46 | IKBKE | 1.21836791 |
47 | MAP2K3 | 1.21816220 |
48 | MET | 1.20044809 |
49 | ATR | 1.19904573 |
50 | TAF1 | 1.15888136 |
51 | PKN2 | 1.15818128 |
52 | EIF2AK1 | 1.13404298 |
53 | PIM2 | 1.10555808 |
54 | EPHA2 | 1.10438536 |
55 | MKNK1 | 1.10282039 |
56 | DYRK2 | 1.08774976 |
57 | MAP3K11 | 1.07274038 |
58 | AURKB | 1.01706460 |
59 | MAP3K3 | 1.01653950 |
60 | BLK | 1.01586684 |
61 | PINK1 | 1.01453688 |
62 | EIF2AK3 | 1.00148483 |
63 | PLK2 | 0.99168120 |
64 | JAK2 | 0.94855441 |
65 | CSK | 0.94005814 |
66 | TESK2 | 0.92389439 |
67 | LIMK1 | 0.92182254 |
68 | MAP4K2 | 0.91648567 |
69 | JAK1 | 0.90624801 |
70 | ZAP70 | 0.88786249 |
71 | IKBKB | 0.88282546 |
72 | DAPK1 | 0.87384646 |
73 | STK38L | 0.87199832 |
74 | AURKA | 0.86385933 |
75 | TLK1 | 0.86092491 |
76 | PRKCI | 0.83728404 |
77 | MAPK4 | 0.83145967 |
78 | TNIK | 0.82228060 |
79 | TRIB3 | 0.80841665 |
80 | BCR | 0.79492480 |
81 | TESK1 | 0.78993730 |
82 | CSF1R | 0.78974217 |
83 | EIF2AK2 | 0.77979190 |
84 | MAP2K2 | 0.76633024 |
85 | TEC | 0.76596262 |
86 | IRAK4 | 0.75238573 |
87 | KIT | 0.73568754 |
88 | NEK2 | 0.73395401 |
89 | BTK | 0.73203213 |
90 | CDK8 | 0.73094286 |
91 | MAP2K4 | 0.73035828 |
92 | CSNK1G2 | 0.71685543 |
93 | CAMK2G | 0.70738700 |
94 | CSNK1A1L | 0.67823808 |
95 | ITK | 0.67204105 |
96 | PTK6 | 0.66791716 |
97 | MAPK15 | 0.64661262 |
98 | ATM | 0.63967356 |
99 | MAP3K8 | 0.63804679 |
100 | BUB1 | 0.63780415 |
101 | CCNB1 | 0.63600113 |
102 | CSNK2A2 | 0.63547383 |
103 | PRKCQ | 0.63262899 |
104 | CLK1 | 0.63167762 |
105 | STK4 | 0.62819648 |
106 | CHEK1 | 0.61672494 |
107 | TXK | 0.61034976 |
108 | CDK7 | 0.60664244 |
109 | MINK1 | 0.59740647 |
110 | ACVR1B | 0.59659939 |
111 | PRKAA2 | 0.59326605 |
112 | ARAF | 0.58019654 |
113 | MAP2K7 | 0.56724084 |
114 | AKT3 | 0.55695384 |
115 | PAK4 | 0.55605063 |
116 | MST4 | 0.54565106 |
117 | RPS6KA4 | 0.52562948 |
118 | PAK1 | 0.51958136 |
119 | FRK | 0.51353002 |
120 | NUAK1 | 0.51264208 |
121 | RPS6KA5 | 0.50717292 |
122 | CDK4 | 0.50298292 |
123 | GSK3A | 0.50255064 |
124 | CSNK1G1 | 0.49025428 |
125 | ILK | 0.49012209 |
126 | PRKACG | 0.48564717 |
127 | GRK1 | 0.47750806 |
128 | IRAK1 | 0.47175740 |
129 | LYN | 0.46139713 |
130 | MAP3K7 | 0.45997470 |
131 | PKN1 | 0.45148927 |
132 | DAPK2 | 0.44645210 |
133 | PDPK1 | 0.44308539 |
134 | CSNK1G3 | 0.43946069 |
135 | ERBB3 | 0.43060805 |
136 | MUSK | 0.42510183 |
137 | PRKCZ | 0.42161684 |
138 | JAK3 | 0.42122906 |
139 | PRKCG | 0.41195003 |
140 | MAPKAPK5 | 0.41048780 |
141 | DYRK1B | 0.40277463 |
142 | LRRK2 | 0.40218479 |
143 | PIM1 | 0.40036743 |
144 | STK39 | 0.39718881 |
145 | MAPK12 | 0.39499629 |
146 | MAP2K6 | 0.39182568 |
147 | CDK1 | 0.38326702 |
148 | TGFBR2 | 0.38294727 |
149 | ERBB2 | 0.37365320 |
150 | WNK4 | 0.36869372 |
151 | ADRBK2 | 0.36803557 |
152 | EPHA3 | 0.36271771 |
153 | OXSR1 | 0.35126815 |
154 | PRKCD | 0.35082588 |
155 | WEE1 | 0.34744726 |
156 | CDK6 | 0.34436153 |
157 | CSNK1E | 0.34229323 |
158 | CSNK1A1 | 0.33686390 |
159 | SYK | 0.33452354 |
160 | STK10 | 0.32625280 |
161 | NLK | 0.32074066 |
162 | FGFR1 | 0.31972076 |
163 | CASK | 0.31136634 |
164 | IGF1R | 0.30723704 |
165 | CSNK2A1 | 0.30245041 |
166 | FGFR2 | 0.28362088 |
167 | CDK2 | 0.27400442 |
168 | BRAF | 0.27243299 |
169 | PASK | 0.26432166 |
170 | MYLK | 0.25247132 |
171 | PRKDC | 0.23955813 |
172 | CDK18 | 0.23307182 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15869877 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28560573 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93941073 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.87953024 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.87895457 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.71554447 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70443162 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63229970 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57855465 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56210497 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56102321 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55124384 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37419788 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35983964 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35925252 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16137087 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.11546855 |
18 | RNA polymerase_Homo sapiens_hsa03020 | 2.11308879 |
19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.05989286 |
20 | Homologous recombination_Homo sapiens_hsa03440 | 2.04666556 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04135366 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99984947 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98969504 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96180040 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94488688 |
26 | Ribosome_Homo sapiens_hsa03010 | 1.89320049 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89023412 |
28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86739299 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81331490 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78165289 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.77881482 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.76625320 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72357638 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70885534 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70228607 |
36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.69289514 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69132575 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67043624 |
39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66624666 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62085818 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59247323 |
42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58636083 |
43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56411226 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55960680 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54514597 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53306197 |
47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50475097 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49362242 |
49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48162066 |
50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47080971 |
51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42762475 |
52 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 1.41188982 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38444437 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36137640 |
55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.34736576 |
56 | RNA transport_Homo sapiens_hsa03013 | 1.33663520 |
57 | Spliceosome_Homo sapiens_hsa03040 | 1.30212689 |
58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24102737 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22926225 |
60 | Bile secretion_Homo sapiens_hsa04976 | 1.22202666 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21260474 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20325449 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18108179 |
64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15867907 |
65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13073499 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09900076 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07756112 |
68 | ABC transporters_Homo sapiens_hsa02010 | 1.07572823 |
69 | RNA degradation_Homo sapiens_hsa03018 | 1.06504076 |
70 | Cell cycle_Homo sapiens_hsa04110 | 1.02537956 |
71 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01304054 |
72 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01042317 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00508943 |
74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99397262 |
75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99191675 |
76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97944130 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97365825 |
78 | Purine metabolism_Homo sapiens_hsa00230 | 0.89854681 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84455935 |
80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68800070 |
81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64163032 |
82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61331997 |
83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61005757 |
84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.60862875 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59072108 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55856652 |
87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53874592 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.52019458 |
89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45299359 |
90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43375749 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42889561 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41595927 |
93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38480388 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37920403 |
95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36676360 |
96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36314673 |
97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36050681 |
98 | Proteasome_Homo sapiens_hsa03050 | 0.31074710 |
99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28241382 |
100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24450895 |
101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24051845 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.23638496 |
103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18612365 |
104 | Protein export_Homo sapiens_hsa03060 | 0.17911498 |
105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17620100 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16305704 |
107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11303703 |
108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.10770023 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10300369 |
110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.09621291 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07287524 |
112 | Insulin resistance_Homo sapiens_hsa04931 | 0.03809069 |
113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03470713 |
114 | Lysosome_Homo sapiens_hsa04142 | 0.00659765 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1104819 |
116 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1084413 |
117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1029726 |
118 | Hepatitis C_Homo sapiens_hsa05160 | -0.1001304 |
119 | Pertussis_Homo sapiens_hsa05133 | -0.0870931 |
120 | Legionellosis_Homo sapiens_hsa05134 | -0.0838840 |
121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0577436 |
122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0508419 |
123 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0397795 |
124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0382456 |
125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0361412 |
126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0191052 |
127 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0152421 |